Cargando…

Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center

BACKGROUND: Transfusion‐dependent thalassemia patients are at high risk of transfusion‐related complications. Yet, there is scanty data on the frequency of transfusion reactions, particularity alloimmunization among pediatric transfusion‐dependent thalassemia patients. In addition, there is no conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarrabian, Dorsa, Hanna, Mirette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623514/
https://www.ncbi.nlm.nih.gov/pubmed/37665129
http://dx.doi.org/10.1002/jcla.24962
_version_ 1785130754214199296
author Zarrabian, Dorsa
Hanna, Mirette
author_facet Zarrabian, Dorsa
Hanna, Mirette
author_sort Zarrabian, Dorsa
collection PubMed
description BACKGROUND: Transfusion‐dependent thalassemia patients are at high risk of transfusion‐related complications. Yet, there is scanty data on the frequency of transfusion reactions, particularity alloimmunization among pediatric transfusion‐dependent thalassemia patients. In addition, there is no consensus on the prophylactic antigen matching for prevention of alloimmunization or the extent of antigen matching for alloimmunized thalassemia patients. METHODS: We conducted a retrospective study to assess the frequency and specificity of alloimmunization among pediatric transfusion‐dependent thalassemia patients receiving ABO, RhD, and K‐matched red blood cell units. In addition, we studied the association between patients' characteristics and alloimmunization. The clinical and transfusion records of transfusion‐dependent thalassemia patients followed up at our institution between July 2018 and June 2022 were reviewed. RESULTS: Ninety‐two transfusion‐dependent thalassemia patients having mean age of 13.37 years (SD, 5.56) were included in our study. Eight patients (9%) had developed clinically significant alloantibodies; six patients (6%) developed alloantibody against E antigen while two patients (2%) developed more than one alloantibody. Of alloimmunized patients, five patients had received transfusion outside Canada. Patients' sex, age, having a genotype variant, total number, and duration of transfusion received were not associated with the risk of alloimmunization. The transfusion‐recipient's diagnosis of β‐thalassemia, having developed autoantibody, and history of receiving transfusion outside Canada were associated with alloimmunization. CONCLUSION: Blood matching for ABO, RhD, and K antigens resulted in, although not eliminated, lower frequency of alloimmunization than that previously reported among pediatric thalassemia patients. Extending matching to include Rh antigens could further reduce the rate of alloimmunization.
format Online
Article
Text
id pubmed-10623514
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106235142023-11-04 Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center Zarrabian, Dorsa Hanna, Mirette J Clin Lab Anal Research Articles BACKGROUND: Transfusion‐dependent thalassemia patients are at high risk of transfusion‐related complications. Yet, there is scanty data on the frequency of transfusion reactions, particularity alloimmunization among pediatric transfusion‐dependent thalassemia patients. In addition, there is no consensus on the prophylactic antigen matching for prevention of alloimmunization or the extent of antigen matching for alloimmunized thalassemia patients. METHODS: We conducted a retrospective study to assess the frequency and specificity of alloimmunization among pediatric transfusion‐dependent thalassemia patients receiving ABO, RhD, and K‐matched red blood cell units. In addition, we studied the association between patients' characteristics and alloimmunization. The clinical and transfusion records of transfusion‐dependent thalassemia patients followed up at our institution between July 2018 and June 2022 were reviewed. RESULTS: Ninety‐two transfusion‐dependent thalassemia patients having mean age of 13.37 years (SD, 5.56) were included in our study. Eight patients (9%) had developed clinically significant alloantibodies; six patients (6%) developed alloantibody against E antigen while two patients (2%) developed more than one alloantibody. Of alloimmunized patients, five patients had received transfusion outside Canada. Patients' sex, age, having a genotype variant, total number, and duration of transfusion received were not associated with the risk of alloimmunization. The transfusion‐recipient's diagnosis of β‐thalassemia, having developed autoantibody, and history of receiving transfusion outside Canada were associated with alloimmunization. CONCLUSION: Blood matching for ABO, RhD, and K antigens resulted in, although not eliminated, lower frequency of alloimmunization than that previously reported among pediatric thalassemia patients. Extending matching to include Rh antigens could further reduce the rate of alloimmunization. John Wiley and Sons Inc. 2023-09-04 /pmc/articles/PMC10623514/ /pubmed/37665129 http://dx.doi.org/10.1002/jcla.24962 Text en © 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Zarrabian, Dorsa
Hanna, Mirette
Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title_full Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title_fullStr Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title_full_unstemmed Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title_short Characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
title_sort characterization of pediatric transfusion‐dependent thalassemia patients in a large academic center
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623514/
https://www.ncbi.nlm.nih.gov/pubmed/37665129
http://dx.doi.org/10.1002/jcla.24962
work_keys_str_mv AT zarrabiandorsa characterizationofpediatrictransfusiondependentthalassemiapatientsinalargeacademiccenter
AT hannamirette characterizationofpediatrictransfusiondependentthalassemiapatientsinalargeacademiccenter